Bristol-Myers Squibb Employees Cycle Coast to Coast to Raise Money and Awareness for Cancer Research
September 07 2016 - 6:59AM
Business Wire
- For the third consecutive year,
teams of Bristol-Myers Squibb employees will cycle across the U.S.
in the Coast 2 Coast 4 Cancer Ride to raise donations in support of
Stand Up To Cancer’s efforts to accelerate research
- Bristol-Myers Squibb will match
money raised, dollar-for-dollar, up to $500,000
Today, the first of six teams of Bristol-Myers Squibb Company
(NYSE:BMY) oncology employees set out from Cannon Beach on the
Oregon coast on the first leg of the 2016 Coast 2 Coast 4 Cancer
Ride, a 21-day cycling ride that will bring together 80 riders
to cover approximately 2,800 miles on a mission for cancer patients
and their loved ones by raising money for Stand Up To Cancer’s
innovative cancer research programs.
As part of the 2016 Coast 2 Coast 4 Cancer Ride,
Bristol-Myers Squibb will match funds raised dollar-for-dollar up
to $500,000, to support Stand Up To Cancer, whose collaborative
“Dream Teams” of scientific researchers are working together to
accelerate cancer research and to provide new treatments to
patients. Last year’s ride raised $841,000 for Stand Up To Cancer
research and this year the goal is even higher – the Coast 2
Coast 4 Cancer Ride aims to reach $1,000,000 in donations.
“I could not be prouder of these riders, many of whom spend the
majority of their time in an office and not on a bike. But they are
committed to doing whatever it takes to help patients fighting
cancer because we all take this cause very personally,” said Chris
Boerner, PhD, president and head of U.S. commercial operations,
Bristol-Myers Squibb. “Everyone on these teams is riding for
someone they know who has been touched by cancer. This year, I’m
riding for my late cousin, whose strength in fighting stomach
cancer inspired me to dedicate my professional career to fighting
cancer.”
One of this year’s riders, Lee Krug, MD, explained, “Like so
many Coast 2 Coast 4 Cancer Ride team members, I have seen
the devastating impact that cancer can have on patients and their
loved ones, but also the strength and endurance that they so often
show. They really are our inspiration on the road. This ride is
about hope and about our combined efforts for patients.”
“One in two men and one in three women in the U.S. will be
affected by cancer, so we all have someone we can stand up for. For
the third year in a row, the Coast 2 Coast 4 Cancer Ride is
standing alongside us as we work to make every person diagnosed
with cancer a survivor,” said Katie Couric, Yahoo Global News
anchor and Stand Up To Cancer co-founder. “You take these
incredibly dedicated riders, and you combine them with
Bristol-Myers Squibb’s commitment to match money raised,
dollar-for-dollar, up to $500,000, and what you have is a truly
powerful, winning team. That’s what patients fighting cancer
deserve, and our hope is that everyone will join us in supporting
the Coast 2 Coast 4 Cancer Ride effort.”
For more information about this epic team effort and to follow
the riders as they cross the country, visit cancerbikeride.org.
Follow the Ride on Twitter by using #C2C4Cancer.
Join the conversation on Twitter by using #C2C4Cancer.
About Bristol-Myers
Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube and Facebook.
About Stand Up To Cancer
Stand Up To Cancer® (SU2C) raises funds to accelerate the pace
of research to get new therapies to patients quickly and save lives
now. SU2C, a program of the Entertainment Industry Foundation
(EIF), a 501(c)(3) charitable organization, was established in 2008
by film and media leaders who utilize the industry’s resources to
engage the public in supporting a new, collaborative model of
cancer research, and to increase awareness about progress being
made in the fight against the disease. As SU2C’s scientific
partner, the American Association for Cancer Research (AACR) and a
Scientific Advisory Committee led by Nobel Laureate Phillip A.
Sharp, Ph.D., conduct rigorous, competitive review processes to
identify the best research proposals to recommend for funding,
oversee grants administration, and provide expert review of
research progress.
For more information on Stand Up To Cancer, visit
www.standup2cancer.org
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160907005567/en/
Bristol-Myers Squibb:Heather Acker,
973-713-6137heather.acker@bms.comorStand Up To Cancer:Adam Miller,
212-843-8032amiller@rubenstein.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024